The provided website for John Evans, mvalaw.com, is a law firm website and does not contain personal information about. See sector focus and contact routes.
About John Evans
The provided website for John Evans, mvalaw.com, is a law firm website and does not contain personal information about John Evans as an investor. It highlights the firm's legal services, recognitions, and community involvement. Therefore, a bio for John Evans as an investor cannot be extracted from this context.
John Evans at a glance
Role
Angel Investor
Location
Cambridge, MA, United States
Investor type
Individual/Angel
Focus areas
Mr. Evans joined Agios in September 2009. He possesses more than 10 years of biopharmaceuticals industry experience across a wide range of business functions. Prior to joining Agios, Mr. Evans served as director of product development at Infinity Pharmaceuticals where he led the company's most advanced oncology programs targeting Hsp90. He also established Infinity’s program management, new product planning and investor relations functions. Before Infinity, Mr. Evans held positions in the pharmaceuticals practice of McKinsey & Company, at MedImmune and at Bayer Pharmaceuticals. Mr. Evans earned an MBA in healthcare management from Wharton, a Masters in biotechnology from the University of Pennsylvania, and a B.A. in English from Yale University.
Frequently asked about John Evans
What does John Evans invest in?
John Evans (Cambridge, MA, United States) — sector focus: Mr. Evans joined Agios in September 2009. He possesses more than 10 years of biopharmaceuticals industry experience across a wide range of business functions.….
How do I contact John Evans?
John Evans's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is John Evans headquartered?
John Evans is based in Cambridge, MA, United States.
StartupFundraising tracks this firm record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Cambridge.
